Suzhou Jiecheng Medical Technology Co., Ltd. was established in September 2009. It is a high-tech enterprise focusing on the R&D and manufacturing of high-end cardiovascular medical devices. It has a number of international PCT invention patents, and its innovative technology is in the leading position in the world.

The company was established in September 2009. The R&D team is composed of cardiac surgery expert Dr. Zhang Ji and several domestic and foreign R&D experts. The company's leading project is the development and production of innovative "J-Valve accurate positioning heart valve implantation system" technology.

J-Valve precise positioning of heart valve implantation system" is a minimally invasive surgical technique that does not require thoracotomy or extracorporeal blood circulation. It can greatly reduce the surgical trauma of the patient, shorten the postoperative recovery time, reduce the pain of the patient, and reduce the patient’s pain. The requirements of physical conditions can expand the scope of applicable diseases, improve the treatment effect, and reduce the cost of surgery, so that most patients who need to replace the heart valve can be treated. Other similar products can only be implanted into the heart with the help of imaging technology. -Valve system can completely rely on its own positioning device to assist doctors in completing valve replacement surgery, thereby reducing the risk of surgery, easier to operate and master, and can simplify the heart valve replacement process. The above advantages will help reduce the overall cost of the national healthcare system. Promote the reform of the medical system, reduce medical expenses, and save social medical resources. At the same time, completely change the situation of long-term dependence on imported heart valves, which will help China's minimally invasive medical technology to move to the forefront of the world.

The J-Valve system has won many awards including the "China Medical Device Technology Innovation Award" from the China Medical Device Industry Association. The company was awarded the "High-tech Enterprise of Jiangsu Province" in 2018. The technical inventor Dr. Zhang Ji is an honorary professor of the Department of Cardiovascular Surgery, Peking University Health Science Center.

At present, the J-Valve system has received extensive attention from the medical community at home and abroad. At the same time, the US FDA is also very concerned about this technology and is willing to promote clinical trials in the United States. The J-Valve system was approved for product registration by the State Food and Drug Administration in April 2017 after clinical trials. So far, this product has helped treat thousands of heart valve patients. In addition, the product has also received special admission approval from the Canadian Ministry of Health. At St. Paul's Hospital, Vancouver's largest cardiac surgery hospital, a dozen Canadian patients with severe aortic insufficiency have successfully undergone minimally invasive heart valve replacement. Core technical advantages and rich experience will ensure that this technology maintains its leading position in the market. Liu Fei, the Chinese Consul General in Vancouver, said that in terms of technology, China has always imported high-tech products and technologies from Canada. The J-Valve system is the first high-end medical device in a developed country that uses all Chinese intellectual property rights, which has launched a cooperation between China and Canada. A broad field means that Chinese creation in the field of medical devices will go to the world. The national science and technology authority believes that this invention is of great significance to the heart field all over the world. We believe that the development prospects of the company are very broad, and at the same time strive to build the company into a medical device company in the cardiovascular field.

Corporate Promotion Video

The company was established in September 2009. The R&D team is composed of cardiac surgery expert Dr. Zhang Ji and several domestic and foreign R&D experts. The company's leading project is the development and production of innovative "J-Valve precision positioning heart valve implantation system" technology